• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

Latest News

Thomas Casale, MD
Neffy for patients with anaphylactic symptoms after oral food challenge

February 23rd 2024

Thomas Casale, MD, discusses phase 3 data presented at the 2024 AAAAI Meeting in Washington DC, highlighting neffy's efficacy in pediatric patients at risk for anaphylaxis.

Clinician quiz: AAP clinical practice guideline for treatment of children with obesity | Image Credit: © Daqota - © Daqota - stock.adobe.com.
Clinician quiz: AAP clinical practice guideline for treatment of children with obesity

February 23rd 2024

Sarina Tanimoto, MD, MBA, chief medical officer, ARS Pharma | Image Credit: ARS Pharma
Neffy pharmacokinetic profiles compared to epinephrine injections

February 23rd 2024

Duchenne muscular dystrophy treatment receives Rare Pediatric Disease designation | Image Credit: © luchschenF - © luchschenF - stock.adobe.com.
Duchenne muscular dystrophy treatment receives Rare Pediatric Disease designation

February 22nd 2024

FDA grants Priority Review to pitolisant for pediatric narcolepsy patients | Image Credit: © fizkes - © fizkes - stock.adobe.com.
FDA grants Priority Review to pitolisant for pediatric narcolepsy patients

February 22nd 2024

Latest Videos
Podcasts

All News

© 2024 MJH Life Sciences

All rights reserved.